News & Updates
The Diagnostic and Interventional Cardiology website posted an important article about recent proposed changes by the FDA which may allow Institutional Review Boards (IRB) to waive or alter informed consent requirements for clinical studies that pose minimal risk to human participants. The conditions under which an IRB could do this are limited and detailed in the…
Read More
Meet with Christopher Kata, Director of Sales & Marketing on December 11th & 12th 2018 DEVICETALKS West ! Christopher Kata, Director of Sales & Marketing 905 999-1957 ckata@trialstat.com When: December 11th & 12th 9:00 am – 5:30 pm Where: HILTON ORANGE COUNTY / COSTA MESA, 3050 Bristol St, Costa Mesa, CA 92626 Registration: https://west.devicetalks.com/ …
Read More
Meet with Christopher Kata, Director of Sales & Marketing on November 13th at the OBIO Event “Talking to Doctors & Patients: Using Primary Market Research Data to Seal the Deal with Investors”! Christopher Kata, Director of Sales & Marketing 905 999-1957 ckata@trialstat.com When: November 13th 11:00 am – 2:00 pm Where: 100 College St Suite 150…
Read More
Meet with Christopher Kata, Director of Sales & Marketing on November 9th at the SoCalBio Digital Health Conference! Christopher Kata, Director of Sales & Marketing 905 999-1957 ckata@trialstat.com When: November 9th 8:00 am – 6:30 pm Where: Hotel Maya 700 Queensway Dr, Long Beach, CA 90802 Registration: https://socalbio.org/socalbio-digital-health-confernce/ SoCalBio Digital Health Conference The…
Read More
Meet with Christopher Kata, Director of Sales & Marketing on November 7th at the Bio In The Capital – CLSA networking event in Sacramento! Christopher Kata, Director of Sales & Marketing 905 999-1957 ckata@trialstat.com When: November 7th 5:30 pm – 7:00 pm Where: Urban Roots Brewery & Smokehouse 1322 V St Sacramento, CA 95818 Registration: https://califesciences.org/bio-in-the-capital/ …
Read More
Meet with Christopher Kata, Director of Sales & Marketing on October 29th and 30th at the Life Sciences Future event in Philadelphia! Christopher Kata, Director of Sales & Marketing 905 999-1957 ckata@trialstat.com When: October 29th – 30th 7:00 am – 6:00 pm Where: Pennsylvania Convention Center – Philadelphia, PA Registration: https://lnkd.in/eJJKVaG Welcome…
Read More
The FDA has announced it is taking additioanl steps to improve the security of Medical Devices. The agency will soon release a new draft of premarket guidance document with recommendations to combat growing security threats. “In addition, the agency announced multiple partnerships with manufacturers, hospitals and more — as well as the release of a…
Read More
MassDevice has written an excellent article outlining the benefits Medical Device Trials receive when using a Unified eClinical Suite. “Implementing a unified data platform for medical device trials can yield significant improvements in efficiency, transparency, and standardization, providing resource- and budget-strapped trial teams with accessible, more accurate data for faster, more informed decisions.” Read The…
Read More
James P. Allison of MD Anderson Cancer Center in Houston and Tasuku Honjo of Kyoto University in Japan have won the Nobel Prize in physiology or medicine for advances in harnessing the immune system to fight cancer. Read The Entire Article Here.
Read More
TrialStat Launches Updated TrialStat EDC at SCDM, Introducing New Features to Further Simplify Your Data Management and Study Collaboration Needs – Meet with us at Booth #312 As the volume of per-trial data grows, compliance requirements increase, and Sponsors are more responsible than ever for trial oversight, TrialStat has responded by releasing the next generation…
Read More